Recruiting NCT07709195
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
Oral Mucositis · Total Body Irradiation · Hematological Malignancies
Hematology
3,640 trials in this section
Recruiting NCT05135351
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
Multiple Myeloma · Lymphoma
Not yet recruiting NCT07727083
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
Extranodal NK/T-cell Lymphoma · Aggressive NK-Cell Leukemia · Systemic Chronic Active Epstein-Barr Virus Disease
Not yet recruiting NCT07729397
Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
Diffuse Large B-Cell Lymphoma (DLBCL) · Hodgkin Lymphoma · Peripheral T-cell Lymphoma (PTCL)
Recruiting NCT07727642
Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma
AIDS-related Lymphoma · HIV Infection
Recruiting NCT07654426
The CARDIOPROTECT Trial
Diffuse Large B-cell Lymphoma (DLBCL) · Cardiotoxicity · Lymphoma
Recruiting NCT06763341
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
Not yet recruiting NCT07724457
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Recurrent Burkitt Lymphoma · Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements · Refractory Burkitt Lymphoma
Recruiting NCT07116616
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Recruiting NCT06152809
CIML NK Cells With Venetoclax for AML
Acute Myeloid Leukemia · Acute Myeloid Leukemia Recurrent · Leukemia
Not yet recruiting NCT07712562
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes · Aplastic Anemias · Severe Aplastic Anemia (SAA)
Recruiting NCT07579065
HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT
Hematologic Neoplasm · Hematopoietic Stem Cell Transplantation · Survivorship
Recruiting NCT06580106
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
Leukemia, Myeloid, Acute
Recruiting NCT06563505
A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma
Lymphoma
Recruiting NCT07354074
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Not yet recruiting NCT07726160
A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma
Relapse and/or Refractory Multiple Myeloma
Recruiting NCT07724873
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
Hematopoietic Stem Cell Transplant (HSCT) · GVHD - Graft-Versus-Host Disease · Hematological Malignancy
Recruiting NCT04322383
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
Hairy Cell Leukemia
Not yet recruiting NCT07725705
SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)
PTCL · First Line Treatment
Recruiting NCT05951816
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Systemic Amyloidosis
Recruiting NCT06699771
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Lymphoma, T-Cell
Recruiting NCT04570423
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Solid Tumors · Lymphoma
Recruiting NCT07227311
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Recruiting NCT06252675
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Mantle Cell Lymphoma
Recruiting NCT07285668
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
Hematologic Malignancies
Recruiting NCT07392970
Motixafortide for MRD Sensitization in AML
Acute Myeloid Leukemia · Measurable Residual Disease
Recruiting NCT06445517
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Advanced Solid Tumors · Relapsed/Refractory B-cell Lymphoma
Not yet recruiting NCT07374315
Weight Gain in Pediatric Leukemia Survivors
Leukemia · Pediatric Acute Lymphoblastic Leukemia · Pediatric Acute Lymphoblastic Leukemia in Remission
Recruiting NCT05189639
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Not yet recruiting NCT07726576
Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Not yet recruiting NCT07724652
The AYA Oncology Self-care Movement
Acute Lymphobkastic Leukemia · Medication Adherence
Recruiting NCT07121946
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma Refractory/ Relapsed · DLBCL - Diffuse Large B Cell Lymphoma · Mantle Cell Lymphoma (MCL)
Recruiting NCT02677064
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia · Newly Diagnosed · Relapsed
Not yet recruiting NCT07721350
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
Multiple Myeloma or Amyloidosis
Recruiting NCT07042243
The Florida ASCENT Study
Cancer · Food Deprivation · Food Habits
Recruiting NCT07137637
HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)
Recruiting NCT06634589
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
B-cell Malignancy · Relapsed Cancer · Refractory Cancer
Not yet recruiting NCT07722767
A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients
AML (Acute Myeloid Leukemia)
Recruiting NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy · hATTR-PN
Recruiting NCT06561074
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
T-cell Acute Lymphoblastic Leukemia · T-Cell Lymphoblastic Lymphoma
Recruiting NCT05350748
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Myelodysplastic Syndromes
Recruiting NCT07101445
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Multiple Myeloma
Recruiting NCT06945042
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Acute Myeloid Leukemia
Not yet recruiting NCT07722988
A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes
Recruiting NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Recruiting NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Not yet recruiting NCT07723911
A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL
Precursor B-cell Acute Lymphoblastic Leukemia
Recruiting NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Recruiting NCT06764238
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Acute Lymphoblastic Leukemia ALL · Childhood Leukemia, Acute Lymphoblastic · B Cell Acute Lymphoblastic Leukemia (B-ALL)
Recruiting NCT03190928
Clonal Evolution in Follicular Lymphoma
Follicular Lymphoma
Recruiting NCT05483010
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Clonal Cytopenia of Undetermined Significance · Myelodysplastic Syndromes
Recruiting NCT07151690
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
Systemic Light Chain Amyloidosis
Recruiting NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia
Recruiting NCT06745687
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
High Risk Smoldering Multiple Myeloma
Not yet recruiting NCT07722312
S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation
Relapsed or Refractory Acute Leukemia · Relapsed or Refractory Acute Myeloid Leukemia
Not yet recruiting NCT07717580
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
Cutaneous T-Cell Lymphoma/Mycosis Fungoides · Primary Cutaneous Anaplastic Large Cell Lymphoma
Recruiting NCT07082686
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Recruiting NCT06910670
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Cholangiocarcinoma · Colorectal Cancer · Multiple Myeloma
Not yet recruiting NCT07723703
Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
Acute Myeloid Leukaemia · High Risk Myelodysplastic Syndrome
Recruiting NCT07203534
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Hematologic Malignancy
Recruiting NCT05588154
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Myelodysplastic Syndromes
Enrolling by invitation NCT06664866
AI Echocardiographic Screening of Cardiac Amyloidosis
Cardiac Amyloidosis
Enrolling by invitation NCT04450927
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
Wide Spectrum of Diseases · Hematologic Diseases
Recruiting NCT07549698
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Warm Autoimmune Hemolytic Anemia (WAIHA) · ITP - Immune Thrombocytopenia · Warm Autoimmune Hemolytic Anemia
Not yet recruiting NCT07686107
Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."
Leukemia, Myeloid, Acute
Recruiting NCT05139797
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Cardiac Amyloidosis
Recruiting NCT06765317
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma (DLBCL) · High Grade B Cell Lymphoma
Not yet recruiting NCT07719855
A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma
Follicular Lymphoma ( FL)
Not yet recruiting NCT07454850
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Leukemia, Myeloid, Chronic-Phase
Recruiting NCT05861050
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
Blastoid Variant Mantle Cell Lymphoma · Mantle Cell Lymphoma · Pleomorphic Variant Mantle Cell Lymphoma
Recruiting NCT07494565
Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
Diffuse Large B-Cell Lymphoma (DLBCL) · CD5 Positive
Recruiting NCT06013423
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Acute Leukemia of Ambiguous Lineage · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia
Not yet recruiting NCT06744712
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Pediatric Cancer
Recruiting NCT07719946
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
Haploidentical Hematopoietic Stem Cell Transplant · Hematological Malignancies
Recruiting NCT06072131
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Recruiting NCT04227847
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome · Acute Myeloid Leukemia
Recruiting NCT07094048
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Multiple Myeloma Refractory · Relapsed Multiple Myeloma
Recruiting NCT07422480
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndrome · Anemia
Recruiting NCT06742996
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mantle Cell Lymphoma · B Cell Lymphoma
Not yet recruiting NCT07719348
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndrome Acute Myeloid Leukemia
Recruiting NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Hematologic Neoplasms
Not yet recruiting NCT07621289
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
Cancer · Anticancer Treatment · Cardiovascular Disease Risk Factor
Recruiting NCT07429721
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Multiple Myeloma (MM)
Not yet recruiting NCT07681258
A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
Chronic Myeloid Leukemia
Not yet recruiting NCT07720843
TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)
Relapse Multiple Myeloma · Refractory Multiple Myeloma
Recruiting NCT07008638
Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia · TP53
Recruiting NCT07236502
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
Multiple Myeloma (MM)
Recruiting NCT07719556
Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)
Mantle Cell Lymphoma (MCL)
Recruiting NCT07154823
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Acute Myeloid Leukaemia (AML) · Follicular Lymphoma ( FL)
Recruiting NCT07428707
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)
Recruiting NCT06765109
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung Cancer · Anaplastic Lymphoma Kinase-positive
Recruiting NCT07101705
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
Multiple Myeloma (MM) · Non-Hodgkin Lymphoma (NHL)
Not yet recruiting NCT07678229
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
Extranodal NK/T-cell Lymphoma
Enrolling by invitation NCT06907849
124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome
Lumbar Spinal Stenosis · Carpal Tunnel Syndrome (CTS) · Cardiac Amyloidosis
Not yet recruiting NCT07717177
AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL
Large B-Cell Lymphoma (LBCL)
Recruiting NCT06714591
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Relapsed/Refractory Acute Myeloid Leukemia
Recruiting NCT06096675
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Cardiac Amyloidosis
Recruiting NCT04504526
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
Lymphoma · Multiple Myeloma · Leukemia
Recruiting NCT07560306
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Cardiac Amyloidosis